7-methylxanthine,
7-methylxanthine, 7-(13)C-labeled,
7-Methylxanthine,
552-62-5,
Heteroxanthine,
Heteroxanthin,
7-Methylxanthin,
2,6-Dihydroxy-7-methylpurine,
7-Methyl-1H-purine-2,6(3H,7H)-dione,
Xanthine, 7-methyl-,
3,7-Dihydro-7-methyl-1H-purine-2,6-dione,
7-methyl-3,7-dihydro-1H-purine-2,6-dione,
1H-Purine-2,6-dione, 3,7-dihydro-7-methyl-,
UNII-E9M81NJM6G,
NSC 7861,
7-methyl xanthine,
CCRIS 5818,
7-methyl-3H-purine-2,6-dione,
EINECS 209-019-0,
MFCD00037979,
E9M81NJM6G,
CHEMBL321248,
CHEBI:48991,
PFWLFWPASULGAN-UHFFFAOYSA-N,
NSC-7861,
7-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione,
7-MethylX,
Heteroxanthine (8CI),
ACMC-1AO0T,
7-Methyl-2,6-dioxypurin,
AC1Q6M4W,
SCHEMBL235130,
AC1L29M1,
AC1Q3Z25,
7-methyl-7H-purine-2,6-diol,
BDBM82522,
CTK4G0848,
CTK8E3565,
DTXSID60203696,
NSC7861,
ZINC391789,
KS-000018VJ,
ANW-57632,
PDSP1_001040,
PDSP2_001024,
WLN: T56 BN DN FMVMVJ B1,
AKOS015903147,
CS-W017879,
FCH1114929,
HY-W017163,
MCULE-8342587762,
1H-Purine-2, 3,7-dihydro-7-methyl-,
7-Methylxanthine, >=98.0% (HPLC),
AJ-21108,
AN-45850,
CAS_552-62-5,
ST078879,
1H-Purine-2,6-dione,3,9-dihydromethyl-,
7-methyl-1,3,7-trihydropurine-2,6-dione,
7-Methyl-1H-purine-2,6(3H,7H);-dione,
AX8110885,
LS-162545,
TR-019487,
FT-0672370,
C16353,
2-hydroxy-7-methyl-6,7-dihydro-1H-purin-6-one,
552M625,
I14-19156,
1H-Purine-2,6-dione, 3,7-dihydro-7-methyl- (9CI),
28109-92-4,
InChI=1/C6H6N4O2/c1-10-2-7-4-3(10)5(11)9-6(12)8-4/h2H,1H3,(H2,8,9,11,12,
Methylxanthine,
7-Methylxantine,
D04RKW,
7-MX,
C6H6N4O2,
C6-H6-N4-O2,
CID68374,
AR-1H3739,
c1098,
Adenosine receptor antagonist (myopia), Trier,
29036-21-3,